Renal handling of urea in subjects with persistent axotemia and normal renal function. Fourteen subjects with persistent azotemia and normal glomerular filtration rate were studied hy renal clearances and hormonal determinations to establish the nephron site of altered urea transport and the mechanism(s) responsible for their azotemia. During constant alimentary protein. urea nitrogen appearance was normal and urea clearance was much lower than in 10 age-matched control subjects (23,3:+: 2.1 mlhnin and49.6:+: 2.6 mllmin per 1.73 m 2 • P < 0.(01). Inulin and para-aminohippurate clearances. blood volume and plasma concentration of antidiuretic hormone were within normal limits. During maximal antidiuresis, in spite of greater urea filtered load, the urinary excretion of urea was less. and hoth the maximum urinary osmolality and the free-water reabsorption relative to osmolar clearance per unit of GFR were greater than in control subjects. After sustained water diuresis. the plasma urea concentration markedly decreased to near normal levels in azotemic suhjects, The basal urinary excretion of prostaglandins E2 was significantly reduced in azotcmic subjects and was directly correlated with fractional urea clearance (I' = 0.857. P < 0.(01). An additional of control subjects (lY = 8) showed a marked reduction of clearance of urea after inhibition of prostaglandin synthesis (P < 0,0]). These data suggest that azotemia is due to incrca)sed tubular reabsorption of urea in the distal part of nephron. presumably hecause of increased back diffusion in the papillary collecting duct. accounting for the enhanced maximum urinary osmolality and free-water reabsorption. Renal prostaglandin E2 may partecipate in the pathogenesis of azotemia by altering recycling of urea in the medulla,
Renal handling of urea in subjects with persistent axotemia and normal renal function. Fourteen subjects with persistent azotemia and normal glomerular filtration rate were studied hy renal clearances and hormonal determinations to establish the nephron site of altered urea transport and the mechanism(s) responsible for their azotemia. During constant alimentary protein. urea nitrogen appearance was normal and urea clearance was much lower than in 10 age-matched control subjects (23, 3 :+: 2.1 mlhnin and49.6:+: 2.6 mllmin per 1.73 m 2 • P < 0.(01). Inulin and para-aminohippurate clearances. blood volume and plasma concentration of antidiuretic hormone were within normal limits. During maximal antidiuresis, in spite of greater urea filtered load, the urinary excretion of urea was less. and hoth the maximum urinary osmolality and the free-water reabsorption relative to osmolar clearance per unit of GFR were greater than in control subjects. After sustained water diuresis. the plasma urea concentration markedly decreased to near normal levels in azotemic suhjects, The basal urinary excretion of prostaglandins E2 was significantly reduced in azotcmic subjects and was directly correlated with fractional urea clearance (I' = 0.857. P < 0.(01). An additional of control subjects (lY = 8) showed a marked reduction of clearance of urea after inhibition of prostaglandin synthesis (P < 0,0]). These data suggest that azotemia is due to incrca)sed tubular reabsorption of urea in the distal part of nephron. presumably hecause of increased back diffusion in the papillary collecting duct. accounting for the enhanced maximum urinary osmolality and free-water reabsorption. Renal prostaglandin E2 may partecipate in the pathogenesis of azotemia by altering recycling of urea in the medulla, Plasma urea level is measured as an index of renal function but is generally recognized that it may be raised for reasons other than impairment of renal function [I, 2] . In spite of normal glomerular filtration rate (GFR). in fact, azotemia may be due either to extrarenal factors (such as excessive protein intake. increased catabolism or abnormal urea metabolism) [3. 4] or to renal causes. Azotemia of renal origin has been attributed to an increase of net urea reabsorption. such as during salt depletion [5] . during diuretic therapy [6] and, in single subjects, because of a genetic defect in renal handling of urea (familial azotemia) 17 . In the last study [7] , renal clearance studies were performed in two subjects and did not allow an establishment of the tubular site nor the intrarenal mechanism responsible for the urea retention, for publication September 8. 19Kfl in revised form March l'l. 1987 In the present investigation, renal clearances and urea nitrogen appearance in 14 subjects with azotemia, as compared with 10 age-matched control indicated that an increase in net tubular reabsorption of urea was responsible for the elevated plasma urea concentration in all subjects, despite a normal renal function, The aim of this study was, therefore, to indicate the nephron site of altered urea transport and the intrarenal mechanism(s) responsible for the decrease in urea excretion, using renal clearances antidiuresis and water diuresis, and determination of concentration of antidiuretic hormone (AD H) and urinary excretion of renal prostaglandin (PG s )' It has been recently shown in animals, in fact, that renal PG s may directly affect the tubular handling of urea [8] .
Methods

Subjects
The study was performed in 14 subjects with persistent azotemia (11 men and 3 women) and normal serum creatinine level and in lO control subjects (10 men), matched for age with azotemie subjects. The age of azotemic subjects, ranging from 29 to 5] years with a mean value of 37.5, was similar to the age of the control subjects (mean: 36.9: range, 26 to 50 years). Persistent azotemia was defined as values of plasma urea concentration greater than or equal to 60 (10 mmollliter) for at least one year. All subjects received a controlled diet with constant intake of protein (1 g/kg of wt), sodium (100 mmol per day), phosphorus (35 mmol per and calories (30 kCallkg of body wt) throughout the study. The subjects were taking no medications for at least one month before the study; none of the azotemic subjects were aspirin or other nonsteroidal anti-inflammatory agents; the use of alcohol, tobacco, tea, and coffee was prohibited. A of stabilization was allowed until body weight and plasma urea concentration were constant, and the magnitude of changes in urinary sodium and phosphorus did not exceed 10% in three consecutive days. In each subject with azotemia, medical physical examination, radiographic and laboratory for signs of renal disease were performed. The subjects gave their informed consent to participate in the study.
Study design
Clearance studies and hormonal determinations were perthe lnternational of Nephrology formed in all subjects during basal antidiuresis and water diuresis. These three different conditions were randomized and separated at least a one week interval. Basal period.
morning for three days, body weight was registered at 8:30 a.m. and blood was obtained at 9 a.m. for determination of plasma urea, creatinine, sodium, potassium and osmolality. The mean concentration in two consecutive samples was taken as the average plasma concentration in the corresponding 24-hour interval. Urinary excretion of urea, creatinine, sodium, potassium, and osmolality were measured by 24-hour urine collections. Daily urea nitrogen appearance (UNA) was calculated according to Walser et al [9] as:
where j and f indicate initial and final values for the period of measurements, respectively; PUN is plasma urea nitrogen; BW is body weight; 0.60 is the fraction of BW representing urea compartment and is urea nitrogen excretion. In the same three of the basal period, plasma renin activity (PRA) and plasma antidiuretic hormone (ADH) were measured on samples obtained at 9 a.m. after two hours of standing position. GFR and renal plasma flow were estimated by inulin and para-aminohippurate clearances in the morning, with the subjects in the recumbent position; a constant infusion containing inulin and para-aminohippuni.te (PAH) (0. was given intravenously. After an equilibration period of at least 45 minutes, urine was collected by spontaneous voiding at intervals of 60 to 80 minutes, and blood was sampled at the beginning and the end of the collection period. The mean of at least three consecutive clearance periods was used as a measure of GFR and renal plasma flow.
For the evalation of urinary excretion of PGE 2 and 6-keto-PGF]a, sexual was avoided for at least two to three days prior to urine collection in order to avoid potential interference of prostatic with urinary PG s . Urinary excretion of PGE 2 and 6-keto-PGF 1a were measured on the same days of urea clearance determinations; urine was refrigerated immediately after collection and samples were stored at -20°C until the assay. Plasma volume was determined by Evan's blud dilution. Screening of plasma urea and creatinine was also performed in consanguineous relatives of azotemic subjects.
Additional study. In eight of the ten normal subjects under study the effect of on fractional clearance of urea were also evaluated. Three basal clearance peri04s of one hour each were followed by the oral administration of 500 mg of aspirin and by three additional clearance periods of one hour. Blood Was sampled at the beginning and the end of each urine collection. Creatinine, urea, sodium, potassium concentration and osmolality were measured in blood and urine and the clearances calculated.
Maximal antidiuresis. Food and fluid were witheld 12 hours before the study. Experiments began at the same hour (9 a.m.) one hour after the administration of l-desamino-8-D-arginine vasopressin (30 {-Lg intranasal route). Urine was collected each hour until urine osmolality reached a maximum and plateaued. Blood was sampled at the beginning and the end of each urine collection. Creatinine, urea, sodium, potassium concentration, and osmolality were measured in blood and urine, and the clearances were calculated.
Maxima/water diuresis. All were deprived of food but not of water for 12 hours before the stltdy. Maximal water diuresis was induced by an oral load (30 mllkg of body wt in 30 min) at 7 a. m. The subjects voided at the end of each 20 minute intervaL and matched urinary output plus insensible fluid losses of I mt/min with tap water by mouth for seven hours. Urine was collected each 20 minutes and the same clearance measurements as in maximal antidiuresis were performed.
Analytical
Inulin was determined by method (l 0), P AH by method of Smith et al [Ill, creatinine by a creatinine autoanalyzer (Beckman Instruments, Inc., Fullerton, California, USA), urea by the urease method (Beckman BUN Analyzer), sodium and potassium by a flame photometer (Beckman), and osmolality by an osmometer (Model 250 D, Fiske Associates, Inc .. Uxbridge, Massachusetts).
PRA was measured by of angiotensin I (Sorin Biomedica kit). Plasma ADH concentration was measured by radioimmunoassay (Medical System kit), as previously described [121. Urinary excretion of PG E2 and 6-keto-PGF 1a (the stable hydrolysis of prostacyclin) was measured by radioimmunoassay ods previously reported [13] . 
Results
The 14 azotemic subjects without renal failure were recruited in a time interval of five years (from January 1980 to January 1985) in our Department of Nephrology. No ethnic subgroup could be detected among these all coming from different geographic areas of our country.
In the last day of stabilization sodium averaged 90.4 ± 0.8 SE mmol/day and 89.9 ± 0.9 SE respectively in control and azotemic subjects, that both groups were in similar condition of salt balance. No difference was found in mean arterial pressure (calculated as sum of diastolic pressure and 1/3 of differential pressure) between control and azotemic subjects. All subjects had blood pressure never greater than 140/90 mm Hg, protein excretion less 150 mg/day, and no abnormality of urine sediment.
Basal
As summarized in Table I , the mean plasma urea concentration was 61.5 ± 0.7 mg per deciliter (12.5 mmoliliter) (range, 60 to 70) in azotemic subjects. The mean: value of 24-hour urea clearance in the azotemic group (23.3 ± 2. mllmin, range 9.0 to 35.2 ml/min per j.73 m 2 ) was lower than in control group (49.6 ± 2.6, range 40.0 to 63.6 mllmin per 1.73 me), despite a normal GFR (always greater than 90 ml/min per J.73 m 2 ) measured as creatinine and inulin clearance. No difference was observed in PAH clearance, urine output, UNA, fractional Table I . Basal values of control (C) and awtemic (A) groups under study (mean ± SE)
-----;;;:;;1-;;,;jJ~7 3111 2 - Table 2 . Basal values of control subjects before (B) and after (A) inhibition of prostaglandin synthesis (mean ± SE)
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Uur excretion of IS odium , ratio, blood volume, PRA, and plasma ADH between control and azotemic subjects. The urinary excretion of PGE 2 in the azotemic group was 3.2 ± 0.2 ng/hr (range 1.2 tb 4.5) which was significantly lower than the value (8.0 2:: 0.8 ng/hr: range 4.0 to 12.1) in the control group. In contrast, urinary excretion of 6-keto-PGF la was not different between control and azotemic subjects. As showed in Figure I , a significant direct relationship hetween urinary excretion of PGE 2 and fractional urea clearance (Cu/C er ) was observed in azotemic subjects (I' = 0.857. P < 0.001), In control subjects no correlation was found hetween urinary excretion of PGE 2 and fractional urea clearance.
A screening of plasma levels urea and creatinine was conducted in 251 of 349 blood relatives. Only one subject, a brother of one azotemic subject, showed a value of plasma urea concentration greater than 60 mg/dl (l0 mmcillliter) in spite cif normal function.
As summarized in Table 2 , inhibition of prostaglandin synthesis by aspirin caused a significant decrease of both urinary urea excretion and CuriC er ratio in control subjects, while did not change (2204 ± 130 mg% after aspirin). No difference was rved in Cer·, UOs m , COsn/Cer and fractional on of sodium after inhibition of PG,.
Maxima! wztidillrcsis
3 shows c1eal"'ance data and maximum urine molalities during antidiuresis. Cu/C er was lower in azotemic than in control subjects. Urinary urea excretion was less than in control subjects in spite of greater urea filtered load, while urinary urea concentration was not significantly different be- Table 3 . Summary of clearance data during maximum antidiuresis in control (Cl and azotemic (Al groups (mean ± SE)
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free-water reabsorption; other abbreviations are the same as in Table 1 . To convert plasma urea values to millimoles per , to convert urinary urea excretion values to millimoles per minute, multiply by 0.0167 Table 4 . Summary of clearance data during maximum water diuresis in control (Cl and azotemic (AI groups (mean = sEI free-water generation; other abbreviations are the same as in Table I . To convert plasma urea values to millimoles per to convert urinary urea excretion values to millimoles per minute, mUltiply by 0.0167 tween normal and azotemic subjects (2474 ± 154 and 2131 ± 162 mg%, respeCtively). Maximum urine osmolality was slightly but significantly greater than control subjects; UOs m ranged between 1101 and 197 mOsm/kg or H 2 0 in azotemic subjects and between 958 and 1058 mOsm/kg of H 2 0 in control subjects. Free-water reabsorption relative to osmolar clearance per unit of GFR, calculated as creatinine clearance, was significantly greater in azotemic than in control subjects.
Maximal water diuresis
The data are shown in Table 4 . The sustained water diuresis lead to a similar minimum value in urine osmolality (range 22 to 81 mOsm/kg of and to a similar maximum value in urine output (range 12.8 to 24.0 mllmin:r in' control and azotemic subjects. Seven hours of water diuresis lead to a significant fall in plasma urea concentration in both control and azotemic subjects, from an initial value of 32.7 ± 2.9 mg% (5.4 ± 0.5 mmol/liter) to 25. ± 2.1 mg% (4.2 ± 0.3 mmollliter) (P < 0.025) in control subjects and from an initial value of 58.5 ± 0.8 mg% (9.7 ± 0.1 mmol/liter) to 43.1 ± 1.9 (7.2 ± 0.3 mmol/liter) (P < 0.001) in azotemic subjects. As shown in Table 4 , after seven hours of water diuresis, the plasma urea concentration reo mained greater while CurJC Cr ratio was lower in azotemic than in control subjects. CH,o was within the normal range.
It is important to note that both the increase in urea excretion and the fall in plasma urea concentration from antidiuresis to water diuresis was significantly greater in azotemic than in control subjects (12.3 ± 2.6 mg/min vs. 5.2 ± 1.5 mg/min, P < 0.05 and 18.6 ± 2.2 vs. 7.1 tively). Discussion mg%, P < 0.01, respecPlasma urea concentration is the result of the balance be· tween urea formation and its renal excretion. In our azotemic subjects, extrarenal causes of azotemia (that is, increased urea loads from diets and/or tissue metabolism) could be excluded since azotemia remained unchanged despite normal alimentary protein intake and normal urea appearance. A disproportionate decrease in urea clearance compared with GFR is a well known effect of salt [5] . A decrease in "effective" intravascular volume is known to be associated with a reduced clearance of sodium and urea [14] . This condition known as "prerenal azotemia" was excluded in our azotemi€ subjects, since blood volume, renal plasma flow and fractional excretion of sodium were normal. The decreased urea clearance might have been accounted for by a reduced intake of water. But urine flow rate, urine/plasma osmolality ratio and plasma concentration of ADH were normal in basal conditions, ruling out such a possibility.
The results of our study indicate that persistent azotemia despite a normal renal function is due to a decreased renal clearance of urea, as reported in subjects with familial azotem' [7] . In familial azotemia the defect in renal urea clearance is inherited as an autosomal dominant trait. In our azotemic subjects this type of genetic inheritance was ruled out studies performed in their relatives. Despite that, a gen defect, albeit sporadic, cannot be excluded.
Micropuncture studies have demonstrated that urea is filtered by the glomeruli, reabsorbed and secreted by the tubules of mammalian kidneys r 15J. Thus a defect in any of these processes might impair urea excretion.
Normally the molecule of urea is not bound to plasmatic protein so that urea is filtered by the glomerulus [16] . Theoretically. should a urea-binding protein be produced by the azotemic subjects. filtration of urea would be reduced thereby impairing urea excretion. However, it has been demonstrated by Hsu et al [7J that the separation of proteins by in vitro dialysis on the samples of azotemic subjects did not change the plasma concentration of urea. Therefore. increased protein binding of urea leading to decreased filtration and excretion seems unlikely.
The mechanism of decreased urea excretion in azotemic subjects is due to an alteration in the tubular handling of urea. During basal period. in fact, urea clearance compared with GFR was markedly reduced and. in maximal antidiuresis, it is particularly impressive that the urinary excretion of urea was less than in control subjects in spite of the greater urea filtered load. The latter finding may account for the observed increase both in maximum urine osmolality and in fractional free-water reabsorption relative to osmolar delivery (T¥!'o/Cos m ) through the generation of high medullary solute co'ncentration (the driving force for distal water reabsorption). since urea is the principal inner medullary solute.
For comparing the renal handling of urea in azotemic and control subjects during water diuresis, we have used the clearances of seventh hour in order to avoid the transient increment of urea excretion. called urea exaltation [17] , following the initial period of rapid hydration. After seven hours of water diuresis, the renal diluting ability, evaluated as minimum urine osmolality and generation of free-water, was similar to those of normal controls and the plasma urea concentration exhibited a significant drop to near normal levels. Conceivably, with more chronic hydration azotemic subjects would lower their plasma urea concentration to normal. Thus, in these subjects the azotemic condition may be masked during period of high fluid intake and might be more detected clinically during of water deprivation. The state of hydration is therefore to determine appropriate changes in the fractional Reduction in fractional urea clearance has also been demonstrated by studying the physiologic effects of reducing protein on urea excretion in man and other species r IS, 19]. In s on a low protein diet. the fraction of filtered urea present in early distal convolutions is significantly greater than in rats normal protein diet ; furthermore, more urea is reabfrom collecting duct in the former than in the latter [20] . is interesting to observe that the state of dehydration detera marked increase in plasma urea concentration in rats on w protein; the fraction of excreted filtered urea decreases y with decreasing urine flow rate in low protein but in normal protein animals [21] . These observations in rats compatible with our results in azotemic subjects. The of reducing protein intake on urea excretion, however, y an impaired ability of the kidney to concentrate urine; concentration and osmolality. in fact. were reduced at the illary tip in low protein rats [2 J]. On the contrary, our azotemic subjects exhibited an improved to concentrate urine, as mirrored by their maximum urine osmolality.
The significant decrease in urinary excretion of POE 2 in azotemic subjects and the significant direct correlation of urinary level of PGE 2 with the values of fractional urea clearance seem to suggest a role of these compounds in the pathogenesis of azotemia. Urinary PG s is a valid marker for intrarenal biosynthesis of PG s [22] . Recent observations [S] indicate that renal PO s may alter the tubular handling of urea. It has been demonstrated by microinjection studies, in fact, that the pharmacologic inhibition of prostaglandins and PGF 2a ) synthesis in rats induces a significant increase of urine osmolality and urea reabsorption in the collecting duct, completely reo versed by POE 2 and PGF 2a addition into distal convoluted tubule.
Concerning the finding 'of a significant correlation between POE 2 excretion and fractional urea clearance in azotemic but not in control subjects, POE 2 might operate by a critical thereshold level rather than by a dose-response curve. A small overlap in the range of PGE 2 between the two groups (azotemic 1.2 to 4.5, control 4 to 12.1 ng/hr) is present: the value of one control subject (4.0 ng/hr), in fact, falls below the values of three azotemic subjects (4.5, 4.4 and 4.2 But, while the latter are near to highest PGE 2 values of azotemic subjects (3.9, 3.S, 3.6, 3.4, etc., ng/hr), the value of the control subject clearly falls below the lowest PGE 2 values of control subjects (5.1.6.9, 6.9, 7.1, etc., ng/hr). Thus, if we take out this isolated value, our data appear to be compatible with the mentioned hypothesis of a critical thereshold level for the proposed role of renal POE 2 . Further evidence that PGE 2 appear to inhibit reabsorption of urea was suggested by the acute effects of the administration of cyclooxygenase inhibitors in normal subjects (Table 2) . rnhibition of POE 2 synthesis, in fact, performed according to a protocol already experienced in our laboratory [23] , signifi· cantly reduced fractional clearance of urea in normal subjects (Table 2 ) to approximately the same value attained in azotemic subjects (Table 1 ). The rate of PGE 2 synthesis varies directly with urine flow, so that it can be increased maximal 'water diuresis [24] . The increase in urea excretion and the fall in plasma urea concentration observed in azotemic subjects when going from antidiuresis to water diuresis were significantly greater than in normal subjects. These findings suggest that the increase of prostaglandin synthesis, induced water load, may correct urea retention in azotemic subjects increasing urea excretion.
The reduced renal biosynthesis of PGE:., might affect urea reabsorption by two mechanisms. (1) A reduction in PG s might decrease the inner medullary blood-flow [25] and lead to an enhanced, inner medullary osmotic gradient, thereby increasing the rate of water reabsorption and the transtubular concentration gradient for urea. The finding of unchanged C PAH in azotemic subjects does not rule out the of a signifi· cant change in inner medullary blood flow since C PAH reflects mainly cortical plasma flow and not flow [26] . (2) Animal studies have given evidence that may directly lower the urea permeability of the collecting duct [S] . Passive reabsorption of urea may therefore be enhanced because of a reduced inhibitory action of PO s on the wall permeability to urea in the medullary collecting duct [S] .
There is no evident explanation for the lower urinary excre-tion of PGE 2 in azotemic group. It is known that urinary excretion of PG s varies directly with urine flow rate [27] and that patients with chronic glomerular disease may have a reduced excretion of [28] . The mean urinary volume of azotemic subjects, however, was not different from control subjects and no abnormality of the urine analysis was present.
Experimental studies in animals have suggested that the excessive urea reabsorption is improbable in the distal convoluted tubule and in the cortical collecting duct, since these tubular sites are almost impermeable to urea regardless of whether or not ADH is present [29] . Furthermore, if increased reabsorption of urea in the distal convoluted tubule and cortical collecting duct has been responsible for decreased urea clearance, the urinary concentrating ability would be expected to be impaired by decreasing medullary solute concentration, an effect in contrast with our data.
Urea handling by the medullary collecting duct has been studied by micropuncture and/or tubular perfusion [30] [31] [32] [33] [34] . These studies suggest that the permeability of the papillary collecting duct to urea is much greater than that of the outer medullary collecting duct. Thus, in the present study it is likely that urea transport in the distal segments of the nephron primarily involves reabsorption from the papillary collecting duct, with recycling of urea in to the loop of Henle and the vasa recta.
Taken together, the results of our study 90 not allow an ignoring of abnormal proximal urea reabsorption in the azotemic subjects, but suggest that azotemia is mainly due to increased tubular reabsorption in the distal part of nephron. An enhanced recycling of urea in the medulla may account for the high urinary solute concentration and free-water reabsorption. The reduced renal biosynthesis of PGE 2 may participate in the pathogenesis of azotemia quite indirectly, through a reduced counteracting action on renal effect of ADH. The consequent increase in urine concentration will provide a greater urea concentration gradient between tubular fluid and interstitium, thereby enhancing urea back diffusion. Neither the precise mechanism causing increased urea reabsorption, nor the exact tubular site where this occurs are apparent from the present study.
